Diagnostic evaluation of platelet function disorders

Blood Reviews

Volumn 25, Issue 4, 2011, Pages 169-173

  Hayward, Catherine P M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Acquired platelet function disorders; Dense granule deficiency; Inherited platelet function disorders; Platelet aggregation; Platelet function; Platelet secretion defects

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 1 INHIBITOR; RISTOCETIN; SEROTONIN; VON WILLEBRAND FACTOR;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BERNARD SOULIER DISEASE; BLEEDING DISORDER; BLEEDING TIME; CELL ASSAY; CELL GRANULE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIAGNOSTIC TEST; GENE MUTATION; HEMATOLOGIC DISEASE; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; PATHOGENESIS; PLATELET DENSE GRANULE; PLATELET FUNCTION DISORDER; PLATELET TYPE VON WILLEBRAND DISEASE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

BLOOD PLATELET DISORDERS; HUMANS; PLATELET FUNCTION TESTS; PREVALENCE;

EID: 79957989577     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2011.03.004     Document Type: Article

References (49)

1. Hayward C.P., Rao A.K., Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006, 12(Suppl 3):128-136.
2. Nurden P., Nurden A.T. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008, 99:253-263.
3. Mezzano D., Quiroga T., Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost 2009, 35:242-254.
4. Quiroga T., Goycoolea M., Munoz B., et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2004, 2:892-898.
5. Hayward C.P., Pai M., Liu Y., et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 2009, 7:676-684.
6. Nurden A.T., Nurden P. Inherited disorders of platelets: an update. Curr Opin Hematol 2006, 13:157-162.
7. Watson S.P., Bahou W.F., Fitzgerald D., Ouwehand W., Rao A.K., Leavitt A.D. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 2005, 3:2098-2101.
8. Watkins N.A., Gusnanto A., de Bono B., et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 2009, 113:e1-e9.
9. Israels S.J. Diagnostic evaluation of platelet function disorders in neonates and children: an update. Semin Thromb Hemost 2009, 35:181-188.
10. Quiroga T., Goycoolea M., Matus V., et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol 2009, 147:729-736.
11. Biss T.T., Blanchette V.S., Clark D.S., Wakefield C.D., James P.D., Rand M.L. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder. J Thromb Haemost 2010, 8:1416-1419.
12. McKay H., Derome F., Haq M.A., et al. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004, 104:159-165.
13. Castaman G., Tosetto A., Goodeve A., et al. The impact of bleeding history, von Willebrand factor and PFA-100((R)) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD. Br J Haematol 2010, 151:245-251.
14. Biss T.T., Blanchette V.S., Clark D.S., et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010, 8:950-956.
15. Bowman M., Mundell G., Grabell J., et al. Generation and validation of the condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost 2008, 6:2062-2066.
16. Rodeghiero F., Tosetto A., Abshire T., et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010, 8:2063-2065.
17. Diamandis M., Veljkovic D.K., Maurer-Spurej E., Rivard G.E., Hayward C.P. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis 2008, 19:109-119.
18. Paterson A.D., Rommens J.M., Bharaj B., et al. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood 2010, 115:1264-1266.
19. Althaus K., Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009, 35:189-203.
20. Kunicki T.J., Nugent D.J. The genetics of normal platelet reactivity. Blood 2010, 116:2627-2634.
21. Soranzo N., Rendon A., Gieger C., et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood 2009, 113:3831-3837.
22. Savoia A., De R.D., Panza E., et al. Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost 2010, 103:826-832.
23. Ganly P., Walker L.C., Morris C.M. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leuk Lymphoma 2004, 45:1-10.
24. Vettore S., Scandellari R., Moro S., et al. Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant. Haematologica 2008, 93:1743-1747.
25. Savoia A., Balduini C.L., Savino M., et al. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 2001, 97:1330-1335.
26. Morison I.M., Cramer Borde E.M., Cheesman E.J., et al. A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia. Nat Genet 2008, 40:387-389.
27. Johnson H.J., Gandhi M.J., Shafizadeh E., et al. In vivo inactivation of MASTL kinase results in thrombocytopenia. Exp Hematol 2009, 37:901-908.
28. Ballmaier M., Germeshausen M. Advances in the understanding of congenital amegakaryocytic thrombocytopenia. Br J Haematol 2009, 146:3-16.
29. Geddis A.E. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin North Am 2009, 23:321-331.
30. Butturini A., Gale R.P., Verlander P.C., dler-Brecher B., Gillio A.P., Auerbach A.D. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994, 84:1650-1655.
31. Lo B., Li L., Gissen P., et al. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 2005, 106:4159-4166.
32. Blundell M.P., Worth A., Bouma G., Thrasher A.J. The Wiskott-Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers 2010, 29:157-175.
33. Ciovacco W.A., Raskind W.H., Kacena M.A. Human phenotypes associated with GATA-1 mutations. Gene 2008, 427:1-6.
34. Pai M., Hayward C.P. Diagnostic assessment of platelet disorders: what are the challenges to standardization?. Semin Thromb Hemost 2009, 35:131-138.
35. Hayward C.P., Harrison P., Cattaneo M., Ortel T.L., Rao A.K. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006, 4:312-319.
36. Harrison P., Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009, 35:150-157.
37. Hayward C.P., Moffat K.A., Raby A., et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010, 134:955-963.
38. Cattaneo M., Hayward C.P., Moffat K.A., Pugliano M.T., Liu Y., Michelson A.D. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009, 7:1029.
39. Gunay-Aygun M., Huizing M., Gahl W.A. Molecular defects that affect platelet dense granules. Semin Thromb Hemost 2004, 30:537-547.
40. Christie D.J., Avari T., Carrington L.R., et al. Clinical and Laboratory Standards Institute (CLSI). CLSI document H58-A 2008, 28:1-45. Clinical and Laboratory Standards Institute, Wayne, PA, USA, Available at: URL:. http://www.clsi.org.
41. Moffat K.A., Ledford-Kraemer M.R., Nichols W.L., Hayward C.P. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005, 93:549-553.
42. Jennings I., Woods T.A., Kitchen S., Walker I.D. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol 2008, 61:950-954.
43. Duncan E.M., Bonar R., Rodgers S.E., Favaloro E.J., Marsden K. Methodology and outcomes of platelet aggregation testing in Australia, New Zealand and the Asia-Pacific region: results of a survey from the Royal College of Pathologists of Australasia Haematology Quality Assurance Program. Int J Lab Hematol 2009, 31:398-406.
44. Cattaneo M., Lecchi A., Zighetti M.L., Lussana F. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica 2007, 92:694-697.
45. Linnemann B., Schwonberg J., Mani H., Prochnow S., Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 2008, 6:677-683.
46. Mani H., Luxembourg B., Klaffling C., Erbe M., Lindhoff-Last E. Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol 2005, 58:747-750.
47. Favaloro E.J., Mohammed S. Platelet function testing: auditing local practice and broader implications. Clin Lab Sci 2010, 23:21-31.
48. Hayward C.P., Moffat K.A., Spitzer E., et al. Results of an external proficiency testing exercise on platelet dense-granule deficiency testing by whole mount electron microscopy. Am J Clin Pathol 2009, 131:671-675.
49. Hayward C.P., Moffat K.A., Pai M., et al. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost 2008, 100:134-145.